The bioinformatics tools and functional studies suggested that miR-205-5p promoted CCA progression partly through suppressing HIPK3 expression. Our findings help to clarify the regulatory role of miR-205-5p in the development and progression of CCA and identify novel therapeutic target for CCA. The gene discussed is HIPK3; the disease is cholangiocarcinoma.